Clinical trial
To Study the Efficacy of Intravenous Neostigmine in Resolution of Acute GI Paralysis in Critically Ill Cirrhotics-Prospective Observational Study
NCT06462872 is registered in ClinicalTrials.gov with Institute of Liver and Biliary Sciences, India as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Study the Efficacy of Intravenous Neostigmine in Resolution of Acute GI Paralysis in Critically Ill Cirrhotics-Prospective Observational Study
- Lead sponsor
- Institute of Liver and Biliary Sciences, India
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 15, 2024
- Completion date
- February 27, 2025
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
critically ill cirrhotics